Yale School Of Medicine
Lessons learned from women with INOCA critical to improving patient-centered care
The experiences of women who recounted their journey from first feeling the symptoms of ischemia and no obstructive CAD to receiving their diagnosis could lead to more patient-centered care in clinical practice, researchers reported.
Black students more likely to leave MD-PhD training programs
Black students had greater than 50% odds of leaving MD-PhD programs compared with their peers, a recent study published in JAMA Internal Medicine found.
VIDEO: Novel machine learning algorithm may transform risk prediction in ACL revision
WASHINGTON — In this video, Kinjal Vasavada, MD, discusses a novel machine learning algorithm intended to predict surgical outcomes in the Multicenter ACL Revision Study cohort.
Financial, community wellbeing tied to lower risk for CV death
U.S. counties with higher measures of community, social and financial wellbeing and greater life satisfaction had the lowest rates of CV death, with the most significant elements being financial and community health, data show.
‘This raises the bar’: Phase 2 data show 24% weight loss with triple-agonist retatrutide
SAN DIEGO — Adults with obesity who received the highest dose of a once-weekly injection of retatrutide lost an average of 24.2% of their body weight at 48 weeks compared with placebo, data from a phase 2 study show.
Health care providers must join fight to combat climate change
CHICAGO — Health care providers, institutions and facilities all have roles in reducing global warming and reversing effects of climate change, according to two plenary speakers at ENDO 2023.
Higher peripheral artery disease prevalence, worse outcomes persist among Black adults
Black adults are significantly more likely to develop peripheral artery disease than Hispanic or white adults even when accounting for traditional risk factors, and often present with advanced disease tied to worse outcomes like amputation.
Wearable devices ‘substantially underused’ among people with heart disease
Fewer than one in four people with or at risk for heart disease use wearable devices, with only half of those reporting consistent daily use, researchers reported.
Osimertinib after surgery reduces risk for death by 51% in resected EGFR-mutant NSCLC
CHICAGO — Adjuvant osimertinib conferred a significant OS benefit vs. placebo among patients with resected, EGFR-mutant, stage IB to IIIA non-small cell lung cancer, according to results of the ADAURA trial presented at ASCO Annual Meeting.
Surgery confers higher 5-year survival rates than radiotherapy in early-stage lung cancer
Patients with early-stage non-small cell lung cancer who underwent surgical resection had higher rates of long-term survival than those who received stereotactic body radiation therapy, according to study results.